# Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection

> **NCT01341106** · PHASE4 · TERMINATED · sponsor: **RWTH Aachen University** · enrollment: 7 (actual)

## Conditions studied

- Hepatitis B, Chronic
- Liver Fibrosis

## Interventions

- **DRUG:** Treatment with entecavir(Baraclude®)

## Key facts

- **NCT ID:** NCT01341106
- **Lead sponsor:** RWTH Aachen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-04
- **Primary completion:** 2015-01
- **Final completion:** 2015-04
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** insufficient patient numbers have been recruited
- **Last updated:** 2015-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01341106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01341106, "Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01341106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*